Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals Limited is a biopharmaceutical company based in Melbourne, Australia, focused on the research and development of therapeutic products for human use. Established in 2014, the company specializes in pentosan polysulphate sodium drugs, which are available in injectable form and are intended for the treatment of conditions such as bone marrow edema, respiratory diseases, and alphaviral arthritis. Paradigm Biopharmaceuticals aims to improve patients' health and quality of life through its innovative therapeutic solutions.